Please join us for this webinar where we will explore the landscape of polygenic risk scores (PRS) and how multifactorial risk models are being used to support personalized management strategies for patients.

Learning Objectives:
  1. Describe the historical development and scientific rationale behind polygenic risk scores (PRS) and combined residual risk scores in genetic risk assessment.
  2. Evaluate current literature on the clinical utility and limitations of breast cancer PRS in various healthcare settings.
  3. Identify practical strategies for integrating polygenic risk scores into shared decision-making.

Hear from our Speakers

McCall Larson MS, CGC

McCall Larson, MS, CGC is a certified genetic counselor practicing in oncology at Intermountain Health. She completed her graduate training at the University of Utah Graduate Program in Genetic Counseling in 2017. Along with providing clinical care to patients with hereditary cancer, McCall worked on multiple projects with the Utah Department of Health to increase awareness of and access to genetic services. She also works with Intermountain leadership to implement processes to improve access to genetic testing.

Sarah Pass MMSc, CGC

Sarah is a Certified Genetic Counselor and Medical Science Liaison at Myriad Genetics. She holds a Master’s in Genetic Counseling from Emory University and has worked as an oncology genetic counselor at MD Anderson and the Medical University of South Carolina. For over seven years, she has supported clinical providers in hereditary cancer and precision tumor testing. Sarah currently serves as Vice President of Communications for the South Carolina Genetic Counseling Society and was recently appointed Vice-Chair of the South Carolina Board of Genetic Counselors under the Department of Labor, Licensing, and Regulation. In both roles, she actively promotes the profession and advances genetic knowledge within the community.